Cited by — SUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapy | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite SUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapy.
No admitted local citation edges point to this work yet.
